SCHEMBL30987322

SCHEMBL30987322

COC(C)(C)Cn1cnc2ccc(Sc3cnc(N4CCC5(CC4)CO[C@@H](C)[C@H]5NC(=O)OC(C)(C)C)cn3)c(Cl)c2c1=O

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 20/20 0.42
MAPK3 P27361 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30987302 0.87 PTPN11 (0.51) PTPN11MAPK3MAPK1
SCHEMBL30987289 0.85 PTPN11 (0.48) PTPN11MAPK3MAPK1
SCHEMBL30987358 0.82 PTPN11 (0.41) PTPN11
SCHEMBL30987343 0.82 PTPN11 (0.46) PTPN11MAPK3MAPK1
SCHEMBL30987329 0.81 PTPN11 (0.53) PTPN11MAPK3MAPK1
SCHEMBL24878927 0.81 PTPN11 (0.54) PTPN11MAPK3MAPK1
SCHEMBL27453869 0.80 PTPN11 (0.46) PTPN11MAPK3MAPK1
SCHEMBL31050065 0.80 PTPN11 (0.48) PTPN11
SCHEMBL31050040 0.80 PTPN11 (0.52) PTPN11
SCHEMBL25394480 0.80 PTPN11 (0.52) PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4647433-A1 SHP2 INHIBITOR AND USES THEREOF Kanaph Therapeutics Inc. (KR) 2025-11-12 EP disclosed
WO-2024147703-A1 SHP2 INHIBITOR AND USES THEREOF 주식회사 카나프테라퓨틱스 2024-07-11 WO disclosed